Piergiuseppe Agostoni

Centro Cardiologico Monzino, IRCCS, Milan, Italy; Department of Clinical Sciences and Community Health – Cardiovascular Section, University of Milan, Milan, Italy

  • OrcidID

Articles by Piergiuseppe Agostoni

Pharmacological Therapy of HFrEF in 2025: Navigating New Advances and Old Unmet Needs in An Eternal Balance Between Progress and Perplexities

Massimo Mapelli, Filippo Maria Rubbo, Simona Costantino, et al

Published:

Citation: Cardiac Failure Review 2025;11:e18.

DOI:

https://doi.org/10.15420/cfr.2024.37
Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan

Piergiuseppe Agostoni, Dimitrios T Farmakis, Jose M García-Pinilla, et al

Published:

Citation: Cardiac Failure Review 2019;5(3):155–61.

DOI:

https://doi.org/10.15420/cfr.2019.01.R1
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use

Zoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, et al

Published:

Citation: Cardiac Failure Review 2020;6:e19.

DOI:

https://doi.org/10.15420/cfr.2020.03